BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Amenorrhea News and Headlines
Amenorrhea News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Amenorrhea
news alerts.
Site Map > Biotechnology News > Health News > Amenorrhea
.

Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
Pharmalive.com:  similar ...
Primary Amenorrhea and PCOS Tied to Metabolic Syndrome
Medscape:  similar ...
TopAbstracts in Eating Disorders 07/01/2008
Doctors Guide:  similar ...
Bisphosphonates' Growing Role in Breast Cancer
Pharmacy Times:  similar ...
Low body weight 'key factor in assessing bone mineral density'
MedWire News:  similar ...
Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone
National Womens Health Information Center:  similar ...
Repros' Proellex Shows Statistically Significant Improvement in Primary Endpoint in Phase 2 Trial in the Treatment of Uterine Fibroids
Business Wire:  similar ...
New findings in Cushing syndrome therapy described from Yonsei University
Health & Medicine Week via NewsRx.com:  similar ...
Biotech News: Shareholders alert for Columbia Laboratories Inc
M2 Communications Ltd.:  similar ...
Biotech News: Current Research on Columbia Laboratories Inc
M2 Communications Ltd.:  similar ...
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
Business Wire:  similar ...
Cytyc Announces New UK NICE Clinical Guideline Recommends Endometrial Ablation Instead of Hysterectomy For Most Women with Heavy Menstrual Bleeding
Business Wire:  similar ...
Progesterone Gel
Business Wire:  similar ...
Wyeth Presents Data on a Tissue Selective Estrogen Complex Class for Menopausal Therapy
PR Newswire:  similar ...
Columbia Laboratories Comments on FDA Decision on Adeza's Gestiva
Business Wire:  similar ...
Columbia Laboratories Comments on FDA Reproductive Drugs Advisory Committee Recommendation on 17-OHPC; PROCHIEVE 8% Currently in Phase III Clinical Trial for Prevention of Recurrent Preterm Birth
Business Wire:  similar ...
Columbia Laboratories Completes Enrollment in Pivotal Phase III Study of Prochieve 8% to Prevent Preterm Birth
Business Wire:  similar ...
Premature ovarian failure may be associated with genetic variants of human
Genomics & Genetics Weekly via NewsRx.com:  similar ...
Columbia Laboratories Added to NASDAQ Biotechnology Index
Business Wire:  similar ...
Researchers' data advance stem cell transplantation research
Pain & Central Nervous System Week via NewsRx.com:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.